Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study
about
Estrogen, Estrogen Receptor and Lung CancerRole of bevacizumab in the management of the patient with malignant pleural effusion: more questions than answers.Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non‑small cell lung cancer (Review).Wet M1a non-small cell lung cancer: is it possible to predict recurrence of pleural effusion?
P2860
Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pleural fluid osteopontin, vas ...... on: a prospective cohort study
@ast
Pleural fluid osteopontin, vas ...... on: a prospective cohort study
@en
type
label
Pleural fluid osteopontin, vas ...... on: a prospective cohort study
@ast
Pleural fluid osteopontin, vas ...... on: a prospective cohort study
@en
prefLabel
Pleural fluid osteopontin, vas ...... on: a prospective cohort study
@ast
Pleural fluid osteopontin, vas ...... on: a prospective cohort study
@en
P2093
P2860
P1433
P1476
Pleural fluid osteopontin, vas ...... on: a prospective cohort study
@en
P2093
An-Chen Feng
Li-Han Hsu
Nei-Min Chu
Pei-Chi Hsu
Tien-Ling Liao
P2860
P2888
P356
10.1186/S12885-016-2529-1
P407
P50
P577
2016-07-13T00:00:00Z
P6179
1034632670